David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
CALL
Innovative Industrial Properties
IIPR
$1.57B
| $1.08M | ﹤0.01% |
14,300
| – | – |
|
2877
CALL
PagSeguro Digital
PAGS
$2.49B
| $1.08M | ﹤0.01% |
31,700
| – | – |
|
2878
PUT
Meritage Homes
MTH
$4.71B
| $1.08M | ﹤0.01% |
+35,400
| New | +$1.21M |
|
2879
Amneal Pharmaceuticals
AMRX
$6.27B
| $1.08M | ﹤0.01% |
224,285
+125,081
| +126% | +$435K |
|
2880
First Financial Bankshares
FFIN
$4.83B
| $1.08M | ﹤0.01% |
30,777
-40,627
| -57% | -$1.4M |
|
2881
Navigator Holdings
NVGS
$1.32B
| $1.08M | ﹤0.01% |
80,192
+42,237
| +111% | +$500K |
|
2882
Old National Bancorp
ONB
$9.86B
| $1.08M | ﹤0.01% |
+58,983
| New | +$1.06M |
|
2883
CALL
Tapestry
TPR
$26B
| $1.08M | ﹤0.01% |
+40,000
| New | +$1.04M |
|
2884
PUT
Insmed
INSM
$27.2B
| $1.07M | ﹤0.01% |
45,000
| – | – |
|
|
AMRN
2885
PUT
Amarin Corp
AMRN
$304M
| $1.07M | ﹤0.01% |
2,500
| – | – |
|
|
BLD
2886
DELISTED
TopBuild
BLD
| $1.07M | ﹤0.01% |
10,401
-11,621
| -53% | -$1.21M |
|
|
TCDA
2887
DELISTED
Tricida, Inc. Common Stock
TCDA
| $1.07M | ﹤0.01% |
+28,374
| New | +$1.06M |
|
|
ZIXI
2888
DELISTED
Zix Corporation
ZIXI
| $1.07M | ﹤0.01% |
157,732
-116,769
| -43% | -$807K |
|
2889
PUT
Delek US
DK
$4.34B
| $1.07M | ﹤0.01% |
31,800
| – | – |
|
|
ODP
2890
DELISTED
ODP
ODP
| $1.06M | ﹤0.01% |
38,816
+1,217
| +3% | +$27.1K |
|
2891
TriCo Bancshares
TCBK
$1.73B
| $1.06M | ﹤0.01% |
26,063
-6,319
| -20% | -$241K |
|
|
NE
2892
DELISTED
Noble Corporation
NE
| $1.06M | ﹤0.01% |
871,381
+841,698
| +2,836% | +$1.01M |
|
|
SRDX
2893
DELISTED
Surmodics
SRDX
| $1.06M | ﹤0.01% |
25,633
-11,914
| -32% | -$502K |
|
2894
PUT
National Health Investors
NHI
$3.6B
| $1.06M | ﹤0.01% |
13,000
+4,600
| +55% | +$377K |
|
2895
PUT
DaVita
DVA
$11.5B
| $1.06M | ﹤0.01% |
14,100
| – | – |
|
2896
PUT
American States Water
AWR
$3.56B
| $1.06M | ﹤0.01% |
12,200
+2,200
| +22% | +$195K |
|
2897
LiveRamp
RAMP
$2.29B
| $1.05M | ﹤0.01% |
21,893
-8,874
| -29% | -$399K |
|
2898
Griffon
GFF
$4.57B
| $1.05M | ﹤0.01% |
51,692
-130,735
| -72% | -$2.75M |
|
|
AIMT
2899
DELISTED
Aimmune Therapeutics
AIMT
| $1.05M | ﹤0.01% |
+31,315
| New | +$875K |
|
|
PRTK
2900
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.05M | ﹤0.01% |
260,083
+242,063
| +1,343% | +$840K |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.